The cost-effectiveness of antenatal varicella screening with post-partum vaccination of susceptibles

A. Pinot De Moira, W. J. Edmunds, J. Breuer*

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    23 Citations (Scopus)


    Varicella infection during pregnancy or around the time of birth can result in serious complications for the mother and/or her child. However, infection during pregnancy is relatively rare as most women are infected during childhood. Immigrant mothers from certain tropical countries are at increased risk of infection, as these countries appear to have lower rates of infection during childhood. We used a cohort model to assess the potential costs and benefits of screening first-time pregnant mothers and then vaccinating those who are susceptible. The model was stratified by age and country of birth (Bangladesh or UK). The strategies evaluated were: (a) an initial verbal screen followed by a serological screen for those with a negative or uncertain history; (b) universal serological screening; and (c) the current strategy which is to treat cases as they arise. Post-partum vaccination was given to those who screen negative for VZV antibodies. The model suggested that the screening and vaccination strategies prevent cases in women compared with the current strategy. Verbal followed by serological screening may be cost-saving to the NHS for both UK- and Bangladesh-born women. Universal screening is more costly but more effective than verbal screening, and it may be cost-effective to universally screen younger immigrant mothers.

    Original languageEnglish
    Pages (from-to)1298-1307
    Number of pages10
    Issue number9
    Publication statusPublished - 27 Feb 2006

    Bibliographical note

    Funding Information:
    We thank Yamima Talukder for the data on seroprevalence of VZV, Dr. Anna Livingtone of the Nightingale practice, Dr. Nicola Hagrup of the Jubilee Road practice, for general practice data, Dr. Ajay Sinha and Dr. Joe Acquilina for the costs of fetal and neonatal management associated with varicella in pregnancy. Dr. Edmunds is in receipt of a grant from the Department of Health.


    • Cost-effectiveness
    • Vaccination
    • Varicella-zoster virus


    Dive into the research topics of 'The cost-effectiveness of antenatal varicella screening with post-partum vaccination of susceptibles'. Together they form a unique fingerprint.

    Cite this